Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Ultra-hypofractionated Radiation in Prostate Cancer [NA]

View source ↗

Summary

A status update for a trial of ultra-hypofractionated radiation therapy in prostate cancer shows the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Early Stage Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING